Prof Intissar Haddiya is a Nephrologist at Mohamed First University, Oujda, MA.

Prof Haddiya's interests include hypertension, kidney disease, dialysis, kidney donation and transplant.

Dr Lund's expertise is in HF big data and registry-based comparative outcomes studies and pragmatic trials. He is active in programs to improve utilisation of existing evidence-based interventions in heart failure with reduced ejection fraction, as well as in novel interventions.

Dr Lars Lund is an Editorial Board member of Cardiac Failure Review.

Marco Metra is Full Professor of Cardiology and Director of the Institute of Cardiology of the Civil Hospital and University of Brescia, Italy, and Editor-in-Chief of the European Journal of Heart Failure and Senior Consulting Editor of the European Heart Journal.

Prof Metra has been principal investigator and member of the Executive or Steering Committees of many trials in patients with heart failure. His research is focused on heart failure with, as main areas of interest, β-blocker therapy and, more recently, the assessment and treatment of the patients with acute heart failure.

He has co-chaired with Prof. Teerlink, San Francisco, CA, the phase IIB Pre-RELAX-AHF and the phase III RELAX-AHF randomized placebo controlled trials in patients with acute heart failure and is chairing the current RELAX-AHF-2 trial, which has as primary end-points the effects of serelaxin on the 180-days mortality and on in-hospital worsening heart…

Prof Dr Marx is a distinguished Professor of Medicine and Cardiology at the RWTH University Hospital Aachen, Germany. His clinical and research interests are centrally focused on cardiovascular disease in patients presenting with significant comorbidities, including Type 2 diabetes mellitus and chronic kidney disease. Prof Marx is a recognised authority on the interplay between metabolic disorders and cardiovascular health. He has contributed significantly to clinical guidelines and trials in this domain, making him a prominent figure in bridging diabetology and cardiology, and frequently serving as faculty at major international congresses.

Prof Peter Rossing is a Clinical Professor at University of Copenhagen, Copenhagen, DK.

His interests include complications in diabetes with focus on renal and cardiovascular complications.

He has been involved in several intervention studies in patients with overt diabetic nephropathy aiming at improving the prognosis.

Prof Rossing is past president of the Danish Endocrine Society, and of the European Diabetic Nephropathy Study group and chairman of the Danish National Diabetes Registry.

Giuseppe Rosano was born and raised in Vibo Valentia, Italy, where he developed an early interest in medicine and cardiovascular science. While detailed information about his family and early childhood is not widely published, his Italian background and international academic career reflect strong cultural roots combined with global engagement in cardiovascular medicine.

Academic History

Professor Rosano obtained his Medical Degree in Medicine and Surgery with full honours from La Sapienza University of Rome in 1988. He subsequently completed his specialisation in Cardiology in 1992. Following his clinical training, he pursued advanced academic and research qualifications in the United Kingdom, earning both an MSc and a PhD in Medical Sciences from Imperial College London. His postgraduate research focused on cardiovascular physiology and pharmacology, forming the foundation of his future work in heart failure and cardiac metabolism.